CXCL13 Marker For Predicting Immunotherapeutic Responsiveness In Patient With Lung Cancer… Application US-20210363593-A1 United States of America 25 Nov 2021
CXCL13 MARKER FOR PREDICTING IMMUNOTHERAPY RESPONSIVENESS IN LUNG CANCER PATIENT AND USE… Application WO-2021086014-A1 World Intellectual Property Organisation (WIPO) 06 May 2021